ad

4 Largecap Stocks Valued Between Rs 3 and Rs 5 Lakh Crore to Watch for Future Multibagger Potential: Sun Pharma, Adani Ports, Titan and HAL

Sun Pharma Rs 1,743. Adani Ports Rs 1,766. Titan Rs 4,424.20. HAL Rs 4,959. Market caps from Rs 3.33 lakh crore to Rs 4.22 lakh crore. Data as of 20 Oct 2026.


21 Oct 2026 • 11:47 am

4 Largecap Stocks Valued Between Rs 3 and Rs 5 Lakh Crore to Watch for Future Multibagger Potential: Sun Pharma, Adani Ports, Titan and HAL

Quick Answer

Sun Pharma, Adani Ports, Titan and HAL are the 4 picks in this stocks valued between Rs 3 and Rs 5 lakh crore watchlist, with market caps between Rs 3.33 lakh crore and Rs 4.22 lakh crore. Sun Pharma stands out for the fastest profit growth, 35.75% a year since FY22, while Adani Ports offers the lowest PE of the group at 30.69. PE ratios run from 30.69 to 68.51, so compare each one with its industry PE before investing. All figures are as of 20 October 2026.

Stocks valued between Rs 3 and Rs 5 lakh crore to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Sun Pharma, Adani Ports, Titan and HAL meet that test, with market caps from Rs 3.33 lakh crore to Rs 4.22 lakh crore and Sun Pharma offering the fastest profit growth, 35.75% a year since FY22. Companies worth Rs 3 lakh crore to Rs 5 lakh crore are among the largest listed businesses in India, yet they still report double-digit growth in several cases.

This list covers companies with a market cap between Rs 3 lakh crore and Rs 5 lakh crore, rising profit and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening stocks valued between Rs 3 and Rs 5 lakh crore usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 20 October 2026 and are drawn from NSE and BSE data and company filings.

Click Here – Get Free Investment Predictions

What Are Stocks Valued Between Rs 3 and Rs 5 Lakh Crore and Why Do They Attract Multibagger Interest?

Stocks valued between Rs 3 and Rs 5 lakh crore are shares of companies that sit just below the very top of the Indian market. They are large enough for mutual funds and foreign investors to hold in size, and each has a clear business engine behind its growth. Together, stocks valued between Rs 3 and Rs 5 lakh crore show how large companies can keep growing.

Companies in this range often have deep liquidity, long track records and strong brands or franchises. Among stocks valued between Rs 3 and Rs 5 lakh crore, those that keep growing profit on a large base are the ones investors compare in stocks valued between Rs 3 and Rs 5 lakh crore. This guide looks at stocks valued between Rs 3 and Rs 5 lakh crore using FY26 results and the latest quarterly numbers. Every one of stocks valued between Rs 3 and Rs 5 lakh crore below has complete, verifiable data.

Stocks Valued Between Rs 3 and Rs 5 Lakh Crore at a Glance: Price, Market Cap, PE and ROE

Prices are closing prices as of 20 October 2026. Adani Ports has the lowest PE of the group at 30.69, while Titan posts the highest return on equity at 32.31%.

Stock CMP (Rs) Market Cap (Rs Cr) PE Industry PE ROE Debt to Equity 52-Week Range (Rs)
Sun Pharmaceutical Industries 1,743 4,22,427 34.86 36.42 13.74% 0.06 1,583.70 to 2,046.90
Adani Ports and Special Economic Zone 1,766 4,02,686 30.69 31.83 13.32% 0.66 1,292.00 to 1,891.10
Titan Company 4,424.20 3,94,621 68.51 46.75 32.31% 0.93 3,506.50 to 5,186.70
Hindustan Aeronautics 4,959 3,33,050 35.73 48.59 22.21% 0.00 3,479.10 to 5,149.90

Sun Pharma: 35.75% Profit CAGR Since FY22

Sun Pharmaceutical Industries is one of India's largest drugmakers and sells generic and specialty medicines in India and overseas. It reported FY26 revenue of Rs 61,673.94 crore, up 12.69% year on year, and net profit of Rs 11,564.52 crore, up 5.32%. Net profit has compounded at 35.75% a year since FY22, while revenue has grown 11.62% a year. Operating margin was 31.47% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.

In the June 2026 quarter, revenue rose 11.93% to Rs 16,023.50 crore and net profit grew 26.41% to Rs 2,910.80 crore. The share price has gained 110.81% over five years. Domestic institutions raised their holding from 20.23% in September 2025 to 22.27% in September 2026. The stock trades at a PE of 34.86 against an industry PE of 36.42, below the sector average, with a return on equity of 13.74%.

Adani Ports: 26.74% Profit CAGR Since FY22

Adani Ports and Special Economic Zone is India's largest private port operator, with ports on both coasts and a growing logistics business. It reported FY26 revenue of Rs 40,854.36 crore, up 26.16% year on year, and net profit of Rs 12,782.03 crore, up 15.56%. Net profit has compounded at 26.74% a year since FY22, while revenue has grown 20.55% a year. Operating margin was 64.59% in FY26.

The stock trades at a PE of 30.69 against an industry PE of 31.83, below the sector average, with a return on equity of 13.32%. In the June 2026 quarter, revenue rose 23.90% to Rs 11,673.71 crore and net profit grew 10.24% to Rs 3,649.50 crore. The share price has gained 115.30% over five years and 17.95% over the past year. Foreign investors raised their holding from 13.61% in September 2025 to 15.95% in September 2026.

Titan: 23.26% Profit CAGR Since FY22

Titan Company runs the jewellery (Tanishq), watches (Titan), eyewear and fragrances businesses. It reported FY26 revenue of Rs 88,136 crore, up 44.62% year on year, and net profit of Rs 5,073 crore, up 52.02%. Net profit has compounded at 23.26% a year since FY22, while revenue has grown 32.00% a year. Operating margin was 10.06% in FY26.

In the June 2026 quarter, revenue rose 29.31% to Rs 21,502 crore and net profit grew 62.88% to Rs 1,777 crore. The share price has gained 72.39% over five years and 22.47% over the past year. Domestic institutions raised their holding from 12.78% in June 2025 to 15.34% in June 2026. The stock trades at a PE of 68.51 against an industry PE of 46.75, with a return on equity of 32.31%.

HAL: Return on Equity of 22.21%

Hindustan Aeronautics is India's state-owned aerospace company that designs, makes and services fighter jets, helicopters, engines and avionics. It reported FY26 revenue of Rs 36,787.95 crore, up 9.68% year on year, and net profit of Rs 9,115.52 crore, up 8.98%. Net profit has compounded at 15.74% a year since FY22, while revenue has grown 9.48% a year. Operating margin was 40.89% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.

The stock trades at a PE of 35.73 against an industry PE of 48.59, below the sector average, with a return on equity of 22.21%. In the June 2026 quarter, revenue rose 15.26% to Rs 6,415.41 crore and net profit grew 14.88% to Rs 1,589.66 crore. The share price has gained 607.71% over five years. Domestic institutions raised their holding from 8.71% in September 2025 to 12.56% in September 2026.

Stocks Valued Between Rs 3 and Rs 5 Lakh Crore: Financial Comparison on Growth and Margins

The table compares scale and growth across these stocks valued between Rs 3 and Rs 5 lakh crore. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.

Stock Revenue (Rs Cr) Net Profit (Rs Cr) Revenue Growth (YoY) 4-Year Revenue CAGR 4-Year Net Profit CAGR Operating Margin (Latest Quarter)
Sun Pharma 61,673.94 11,564.52 12.69% 11.62% 35.75% 32.52%
Adani Ports 40,854.36 12,782.03 26.16% 20.55% 26.74% 65.67%
Titan 88,136 5,073 44.62% 32.00% 23.26% 14.61%
HAL 36,787.95 9,115.52 9.68% 9.48% 15.74% 44.22%

Check the Univest Screener for live data on these stocks valued between Rs 3 and Rs 5 lakh crore

Institutional Holding in Sun Pharma, Adani Ports, Titan and HAL

Institutional holding shows who is backing these stocks valued between Rs 3 and Rs 5 lakh crore alongside the promoter. The table uses the latest reported quarter for each. Sun Pharma has the deepest institutional backing, with FII and DII together holding 36.63% as of September 2026. Domestic institutions increased their holding over the past year in Sun Pharma (from 20.23% to 22.27%), Titan (from 12.78% to 15.34%) and HAL (from 8.71% to 12.56%).

Stock Promoter FII DII Public Quarter
Sun Pharma 52.68% 14.36% 22.27% 10.70% September 2026
Adani Ports 66.03% 15.95% 13.25% 4.77% September 2026
Titan 52.90% 15.38% 15.34% 16.38% June 2026
HAL 71.64% 9.42% 12.56% 6.38% September 2026

Risks to Weigh in Stocks Valued Between Rs 3 and Rs 5 Lakh Crore

Being careful with stocks valued between Rs 3 and Rs 5 lakh crore means looking at what can slow the story as well as what can speed it up. Four points matter most:

  • Market cap changes every day with the share price.
  • Growth may ease as the base gets larger.
  • Valuation: Titan trades at a PE of 68.51 against an industry PE of 46.75, so earnings need to keep growing to support the price.
  • Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.

How to Choose Between Stocks Valued Between Rs 3 and Rs 5 Lakh Crore

Picking from stocks valued between Rs 3 and Rs 5 lakh crore comes down to four checks, applied in order.

  1. Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
  2. Compare each PE with the industry PE (31.83 to 48.59) and ask whether the growth rate justifies any gap.
  3. Track quarterly profit growth, the return on equity and institutional holding in every result.
  4. Stagger entries across quarters and review institutional holding every reporting season.

Download the Univest iOS App or Univest Android App to track Sun Pharma, Adani Ports, Titan and HAL live prices.

Conclusion

Among stocks valued between Rs 3 and Rs 5 lakh crore, Sun Pharma stands out for the fastest profit growth, 35.75% a year since FY22, Adani Ports for the lowest PE of the group at 30.69, Titan for the highest return on equity at 32.31% and HAL for the biggest five-year price gain at 607.71%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing stocks valued between Rs 3 and Rs 5 lakh crore should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions on Stocks Valued Between Rs 3 and Rs 5 Lakh Crore to Watch

Which are the best stocks valued between Rs 3 and Rs 5 lakh crore to watch for multibagger potential?

Ans. Sun Pharma, Adani Ports, Titan and HAL are the 4 names this list highlights, with market caps of Rs 4,22,427 crore, Rs 4,02,686 crore, Rs 3,94,621 crore and Rs 3,33,050 crore respectively. Sun Pharma is notable for the fastest profit growth, 35.75% a year since FY22. Adani Ports stands out for the lowest PE of the group at 30.69. Titan offers the highest return on equity at 32.31%. HAL brings the biggest five-year price gain at 607.71%. These are watchlist names for stocks valued between Rs 3 and Rs 5 lakh crore, not recommendations, so match each one to your own risk profile and time horizon.

Is Titan a good stock for long-term investors?

Ans. Titan has a return on equity of 32.31%, a PE of 68.51 against an industry PE of 46.75 and a market cap of Rs 3,94,621 crore. Net profit has compounded at 23.26% a year since FY22, and FY26 revenue rose 44.62% while June 2026 quarter net profit grew 62.88%. Long-term returns in stocks valued between Rs 3 and Rs 5 lakh crore depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.

Can Sun Pharma become a multibagger from here?

Ans. Sun Pharma has already gained 110.81% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in stocks valued between Rs 3 and Rs 5 lakh crore requires earnings to keep growing faster than the market for several years. Net profit has compounded at 35.75% a year since FY22, and FY26 revenue rose 12.69%. At a PE of 34.86 against an industry PE of 36.42, valuation should be checked against that growth before investing.

What is the market cap of Sun Pharma, Adani Ports, Titan and HAL?

Ans. As of 20 October 2026, Sun Pharma has a market cap of Rs 4,22,427 crore, Adani Ports has a market cap of Rs 4,02,686 crore, Titan has a market cap of Rs 3,94,621 crore and HAL has a market cap of Rs 3,33,050 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on stocks valued between Rs 3 and Rs 5 lakh crore.

What are the risks of investing in stocks valued between Rs 3 and Rs 5 lakh crore?

Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Titan trades at a PE of 68.51 against an industry PE of 46.75, so earnings growth needs to hold up.

Why is Titan trading at a PE of 68.51?

Ans. Titan's PE of 68.51 compares with an industry PE of 46.75. The market is paying a premium for a return on equity of 32.31%, profit growth of 23.26% a year since FY22 and latest-quarter profit growth of 62.88%, which also means the stock is more sensitive if growth slows. Investors in stocks valued between Rs 3 and Rs 5 lakh crore who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.

How much do institutions hold in Sun Pharma, Adani Ports, Titan and HAL?

Ans. As of the latest reported quarter, FII and DII together hold 36.63% of Sun Pharma (14.36% and 22.27%), 29.20% of Adani Ports (15.95% and 13.25%), 30.72% of Titan (15.38% and 15.34%) and 21.98% of HAL (9.42% and 12.56%). Rising institutional holding is a useful signal in stocks valued between Rs 3 and Rs 5 lakh crore, though it should be read with earnings trends rather than on its own.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down